▶ 調査レポート

世界の滅菌液用BFS技術市場(~2028年):ポリプロピレン(PP)シリンジ、ポリ塩化ビニル(PVC)シリンジ、その他

• 英文タイトル:Global BFS Technology for Sterile Liquids Market Insights, Forecast to 2028

Global BFS Technology for Sterile Liquids Market Insights, Forecast to 2028「世界の滅菌液用BFS技術市場(~2028年):ポリプロピレン(PP)シリンジ、ポリ塩化ビニル(PVC)シリンジ、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-16732
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、滅菌液用BFS技術のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
滅菌液用BFS技術のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
滅菌液用BFS技術の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
滅菌液用BFS技術のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの滅菌液用BFS技術の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の滅菌液用BFS技術の売上および2028年までの予測に焦点を当てています。

滅菌液用BFS技術のグローバル主要企業には、Unither Pharmaceuticals、Nephron Pharmaceuticals、TRC (Ritedose)、Recipharm、Takeda Pharmaceuticals、Catalent、SIFI、New Vision Pharmaceuticals、Pharmapack、Rommelag、Unicep Packaging、Amanta Healthcare、Horizon Pharmaceuticals、SALVAT、Curida、Asept Pak、CR Double-Craneなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

滅菌液用BFS技術市場は、タイプとアプリケーションによって区分されます。世界の滅菌液用BFS技術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
ポリプロピレン(PP)シリンジ、ポリ塩化ビニル(PVC)シリンジ、その他

【アプリケーション別セグメント】
医薬品、食品・飲料、化粧品・パーソナルケア、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 滅菌液用BFS技術製品概要
- タイプ別市場(ポリプロピレン(PP)シリンジ、ポリ塩化ビニル(PVC)シリンジ、その他)
- アプリケーション別市場(医薬品、食品・飲料、化粧品・パーソナルケア、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の滅菌液用BFS技術販売量予測2017-2028
- 世界の滅菌液用BFS技術売上予測2017-2028
- 滅菌液用BFS技術の地域別販売量
- 滅菌液用BFS技術の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別滅菌液用BFS技術販売量
- 主要メーカー別滅菌液用BFS技術売上
- 主要メーカー別滅菌液用BFS技術価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(ポリプロピレン(PP)シリンジ、ポリ塩化ビニル(PVC)シリンジ、その他)
- 滅菌液用BFS技術のタイプ別販売量
- 滅菌液用BFS技術のタイプ別売上
- 滅菌液用BFS技術のタイプ別価格
・アプリケーション別市場規模(医薬品、食品・飲料、化粧品・パーソナルケア、その他)
- 滅菌液用BFS技術のアプリケーション別販売量
- 滅菌液用BFS技術のアプリケーション別売上
- 滅菌液用BFS技術のアプリケーション別価格
・北米市場
- 北米の滅菌液用BFS技術市場規模(タイプ別、アプリケーション別)
- 主要国別の滅菌液用BFS技術市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの滅菌液用BFS技術市場規模(タイプ別、アプリケーション別)
- 主要国別の滅菌液用BFS技術市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の滅菌液用BFS技術市場規模(タイプ別、アプリケーション別)
- 主要国別の滅菌液用BFS技術市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の滅菌液用BFS技術市場規模(タイプ別、アプリケーション別)
- 主要国別の滅菌液用BFS技術市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの滅菌液用BFS技術市場規模(タイプ別、アプリケーション別)
- 主要国別の滅菌液用BFS技術市場規模(トルコ、サウジアラビア)
・企業情報
Unither Pharmaceuticals、Nephron Pharmaceuticals、TRC (Ritedose)、Recipharm、Takeda Pharmaceuticals、Catalent、SIFI、New Vision Pharmaceuticals、Pharmapack、Rommelag、Unicep Packaging、Amanta Healthcare、Horizon Pharmaceuticals、SALVAT、Curida、Asept Pak、CR Double-Crane
・産業チェーン及び販売チャネル分析
- 滅菌液用BFS技術の産業チェーン分析
- 滅菌液用BFS技術の原材料
- 滅菌液用BFS技術の生産プロセス
- 滅菌液用BFS技術の販売及びマーケティング
- 滅菌液用BFS技術の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 滅菌液用BFS技術の産業動向
- 滅菌液用BFS技術のマーケットドライバー
- 滅菌液用BFS技術の課題
- 滅菌液用BFS技術の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for BFS Technology for Sterile Liquids estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for BFS Technology for Sterile Liquids is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for BFS Technology for Sterile Liquids is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for BFS Technology for Sterile Liquids is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of BFS Technology for Sterile Liquids include Unither Pharmaceuticals, Nephron Pharmaceuticals, TRC (Ritedose), Recipharm, Takeda Pharmaceuticals, Catalent, SIFI, New Vision Pharmaceuticals and Pharmapack, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the BFS Technology for Sterile Liquids companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional BFS Technology for Sterile Liquids market. Further, it explains the major drivers and regional dynamics of the global BFS Technology for Sterile Liquids market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Unither Pharmaceuticals
Nephron Pharmaceuticals
TRC (Ritedose)
Recipharm
Takeda Pharmaceuticals
Catalent
SIFI
New Vision Pharmaceuticals
Pharmapack
Rommelag
Unicep Packaging
Amanta Healthcare
Horizon Pharmaceuticals
SALVAT
Curida
Asept Pak
CR Double-Crane
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
BFS Technology for Sterile Liquids Segment by Type
Polypropylene (PP) Syringes
Polyvinyl Chloride (PVC) Syringes
Others
BFS Technology for Sterile Liquids Segment by Application
Pharmaceuticals
Food & Beverage
Cosmetics and Personal Care
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the BFS Technology for Sterile Liquids market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for BFS Technology for Sterile Liquids market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of BFS Technology for Sterile Liquids, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for BFS Technology for Sterile Liquids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the BFS Technology for Sterile Liquids revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global BFS Technology for Sterile Liquids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for BFS Technology for Sterile Liquids revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Unither Pharmaceuticals, Nephron Pharmaceuticals, TRC (Ritedose), Recipharm, Takeda Pharmaceuticals, Catalent, SIFI, New Vision Pharmaceuticals and Pharmapack, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of BFS Technology for Sterile Liquids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BFS Technology for Sterile Liquids companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BFS Technology for Sterile Liquids revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BFS Technology for Sterile Liquids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polypropylene (PP) Syringes
1.2.3 Polyvinyl Chloride (PVC) Syringes
1.2.4 Others
1.3 Market by Application
1.3.1 Global BFS Technology for Sterile Liquids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceuticals
1.3.3 Food & Beverage
1.3.4 Cosmetics and Personal Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global BFS Technology for Sterile Liquids Market Perspective (2017-2028)
2.2 BFS Technology for Sterile Liquids Growth Trends by Region
2.2.1 BFS Technology for Sterile Liquids Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 BFS Technology for Sterile Liquids Historic Market Size by Region (2017-2022)
2.2.3 BFS Technology for Sterile Liquids Forecasted Market Size by Region (2023-2028)
2.3 BFS Technology for Sterile Liquids Market Dynamics
2.3.1 BFS Technology for Sterile Liquids Industry Trends
2.3.2 BFS Technology for Sterile Liquids Market Drivers
2.3.3 BFS Technology for Sterile Liquids Market Challenges
2.3.4 BFS Technology for Sterile Liquids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top BFS Technology for Sterile Liquids Players by Revenue
3.1.1 Global Top BFS Technology for Sterile Liquids Players by Revenue (2017-2022)
3.1.2 Global BFS Technology for Sterile Liquids Revenue Market Share by Players (2017-2022)
3.2 Global BFS Technology for Sterile Liquids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by BFS Technology for Sterile Liquids Revenue
3.4 Global BFS Technology for Sterile Liquids Market Concentration Ratio
3.4.1 Global BFS Technology for Sterile Liquids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BFS Technology for Sterile Liquids Revenue in 2021
3.5 BFS Technology for Sterile Liquids Key Players Head office and Area Served
3.6 Key Players BFS Technology for Sterile Liquids Product Solution and Service
3.7 Date of Enter into BFS Technology for Sterile Liquids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 BFS Technology for Sterile Liquids Breakdown Data by Type
4.1 Global BFS Technology for Sterile Liquids Historic Market Size by Type (2017-2022)
4.2 Global BFS Technology for Sterile Liquids Forecasted Market Size by Type (2023-2028)
5 BFS Technology for Sterile Liquids Breakdown Data by Application
5.1 Global BFS Technology for Sterile Liquids Historic Market Size by Application (2017-2022)
5.2 Global BFS Technology for Sterile Liquids Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America BFS Technology for Sterile Liquids Market Size (2017-2028)
6.2 North America BFS Technology for Sterile Liquids Market Size by Type
6.2.1 North America BFS Technology for Sterile Liquids Market Size by Type (2017-2022)
6.2.2 North America BFS Technology for Sterile Liquids Market Size by Type (2023-2028)
6.2.3 North America BFS Technology for Sterile Liquids Market Share by Type (2017-2028)
6.3 North America BFS Technology for Sterile Liquids Market Size by Application
6.3.1 North America BFS Technology for Sterile Liquids Market Size by Application (2017-2022)
6.3.2 North America BFS Technology for Sterile Liquids Market Size by Application (2023-2028)
6.3.3 North America BFS Technology for Sterile Liquids Market Share by Application (2017-2028)
6.4 North America BFS Technology for Sterile Liquids Market Size by Country
6.4.1 North America BFS Technology for Sterile Liquids Market Size by Country (2017-2022)
6.4.2 North America BFS Technology for Sterile Liquids Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe BFS Technology for Sterile Liquids Market Size (2017-2028)
7.2 Europe BFS Technology for Sterile Liquids Market Size by Type
7.2.1 Europe BFS Technology for Sterile Liquids Market Size by Type (2017-2022)
7.2.2 Europe BFS Technology for Sterile Liquids Market Size by Type (2023-2028)
7.2.3 Europe BFS Technology for Sterile Liquids Market Share by Type (2017-2028)
7.3 Europe BFS Technology for Sterile Liquids Market Size by Application
7.3.1 Europe BFS Technology for Sterile Liquids Market Size by Application (2017-2022)
7.3.2 Europe BFS Technology for Sterile Liquids Market Size by Application (2023-2028)
7.3.3 Europe BFS Technology for Sterile Liquids Market Share by Application (2017-2028)
7.4 Europe BFS Technology for Sterile Liquids Market Size by Country
7.4.1 Europe BFS Technology for Sterile Liquids Market Size by Country (2017-2022)
7.4.2 Europe BFS Technology for Sterile Liquids Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BFS Technology for Sterile Liquids Market Size (2017-2028)
8.2 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Type
8.2.1 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Type (2017-2022)
8.2.2 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Type (2023-2028)
8.2.3 Asia-Pacific BFS Technology for Sterile Liquids Market Share by Type (2017-2028)
8.3 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Application
8.3.1 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Application (2017-2022)
8.3.2 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Application (2023-2028)
8.3.3 Asia-Pacific BFS Technology for Sterile Liquids Market Share by Application (2017-2028)
8.4 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Region
8.4.1 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Region (2017-2022)
8.4.2 Asia-Pacific BFS Technology for Sterile Liquids Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America BFS Technology for Sterile Liquids Market Size (2017-2028)
9.2 Latin America BFS Technology for Sterile Liquids Market Size by Type
9.2.1 Latin America BFS Technology for Sterile Liquids Market Size by Type (2017-2022)
9.2.2 Latin America BFS Technology for Sterile Liquids Market Size by Type (2023-2028)
9.2.3 Latin America BFS Technology for Sterile Liquids Market Share by Type (2017-2028)
9.3 Latin America BFS Technology for Sterile Liquids Market Size by Application
9.3.1 Latin America BFS Technology for Sterile Liquids Market Size by Application (2017-2022)
9.3.2 Latin America BFS Technology for Sterile Liquids Market Size by Application (2023-2028)
9.3.3 Latin America BFS Technology for Sterile Liquids Market Share by Application (2017-2028)
9.4 Latin America BFS Technology for Sterile Liquids Market Size by Country
9.4.1 Latin America BFS Technology for Sterile Liquids Market Size by Country (2017-2022)
9.4.2 Latin America BFS Technology for Sterile Liquids Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BFS Technology for Sterile Liquids Market Size (2017-2028)
10.2 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Type
10.2.1 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Type (2017-2022)
10.2.2 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Type (2023-2028)
10.2.3 Middle East & Africa BFS Technology for Sterile Liquids Market Share by Type (2017-2028)
10.3 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Application
10.3.1 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Application (2017-2022)
10.3.2 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Application (2023-2028)
10.3.3 Middle East & Africa BFS Technology for Sterile Liquids Market Share by Application (2017-2028)
10.4 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Country
10.4.1 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Country (2017-2022)
10.4.2 Middle East & Africa BFS Technology for Sterile Liquids Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Unither Pharmaceuticals
11.1.1 Unither Pharmaceuticals Company Details
11.1.2 Unither Pharmaceuticals Business Overview
11.1.3 Unither Pharmaceuticals BFS Technology for Sterile Liquids Introduction
11.1.4 Unither Pharmaceuticals Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.1.5 Unither Pharmaceuticals Recent Developments
11.2 Nephron Pharmaceuticals
11.2.1 Nephron Pharmaceuticals Company Details
11.2.2 Nephron Pharmaceuticals Business Overview
11.2.3 Nephron Pharmaceuticals BFS Technology for Sterile Liquids Introduction
11.2.4 Nephron Pharmaceuticals Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.2.5 Nephron Pharmaceuticals Recent Developments
11.3 TRC (Ritedose)
11.3.1 TRC (Ritedose) Company Details
11.3.2 TRC (Ritedose) Business Overview
11.3.3 TRC (Ritedose) BFS Technology for Sterile Liquids Introduction
11.3.4 TRC (Ritedose) Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.3.5 TRC (Ritedose) Recent Developments
11.4 Recipharm
11.4.1 Recipharm Company Details
11.4.2 Recipharm Business Overview
11.4.3 Recipharm BFS Technology for Sterile Liquids Introduction
11.4.4 Recipharm Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.4.5 Recipharm Recent Developments
11.5 Takeda Pharmaceuticals
11.5.1 Takeda Pharmaceuticals Company Details
11.5.2 Takeda Pharmaceuticals Business Overview
11.5.3 Takeda Pharmaceuticals BFS Technology for Sterile Liquids Introduction
11.5.4 Takeda Pharmaceuticals Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.5.5 Takeda Pharmaceuticals Recent Developments
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent BFS Technology for Sterile Liquids Introduction
11.6.4 Catalent Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.6.5 Catalent Recent Developments
11.7 SIFI
11.7.1 SIFI Company Details
11.7.2 SIFI Business Overview
11.7.3 SIFI BFS Technology for Sterile Liquids Introduction
11.7.4 SIFI Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.7.5 SIFI Recent Developments
11.8 New Vision Pharmaceuticals
11.8.1 New Vision Pharmaceuticals Company Details
11.8.2 New Vision Pharmaceuticals Business Overview
11.8.3 New Vision Pharmaceuticals BFS Technology for Sterile Liquids Introduction
11.8.4 New Vision Pharmaceuticals Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.8.5 New Vision Pharmaceuticals Recent Developments
11.9 Pharmapack
11.9.1 Pharmapack Company Details
11.9.2 Pharmapack Business Overview
11.9.3 Pharmapack BFS Technology for Sterile Liquids Introduction
11.9.4 Pharmapack Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.9.5 Pharmapack Recent Developments
11.10 Rommelag
11.10.1 Rommelag Company Details
11.10.2 Rommelag Business Overview
11.10.3 Rommelag BFS Technology for Sterile Liquids Introduction
11.10.4 Rommelag Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.10.5 Rommelag Recent Developments
11.11 Unicep Packaging
11.11.1 Unicep Packaging Company Details
11.11.2 Unicep Packaging Business Overview
11.11.3 Unicep Packaging BFS Technology for Sterile Liquids Introduction
11.11.4 Unicep Packaging Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.11.5 Unicep Packaging Recent Developments
11.12 Amanta Healthcare
11.12.1 Amanta Healthcare Company Details
11.12.2 Amanta Healthcare Business Overview
11.12.3 Amanta Healthcare BFS Technology for Sterile Liquids Introduction
11.12.4 Amanta Healthcare Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.12.5 Amanta Healthcare Recent Developments
11.13 Horizon Pharmaceuticals
11.13.1 Horizon Pharmaceuticals Company Details
11.13.2 Horizon Pharmaceuticals Business Overview
11.13.3 Horizon Pharmaceuticals BFS Technology for Sterile Liquids Introduction
11.13.4 Horizon Pharmaceuticals Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.13.5 Horizon Pharmaceuticals Recent Developments
11.14 SALVAT
11.14.1 SALVAT Company Details
11.14.2 SALVAT Business Overview
11.14.3 SALVAT BFS Technology for Sterile Liquids Introduction
11.14.4 SALVAT Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.14.5 SALVAT Recent Developments
11.15 Curida
11.15.1 Curida Company Details
11.15.2 Curida Business Overview
11.15.3 Curida BFS Technology for Sterile Liquids Introduction
11.15.4 Curida Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.15.5 Curida Recent Developments
11.16 Asept Pak
11.16.1 Asept Pak Company Details
11.16.2 Asept Pak Business Overview
11.16.3 Asept Pak BFS Technology for Sterile Liquids Introduction
11.16.4 Asept Pak Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.16.5 Asept Pak Recent Developments
11.17 CR Double-Crane
11.17.1 CR Double-Crane Company Details
11.17.2 CR Double-Crane Business Overview
11.17.3 CR Double-Crane BFS Technology for Sterile Liquids Introduction
11.17.4 CR Double-Crane Revenue in BFS Technology for Sterile Liquids Business (2017-2022)
11.17.5 CR Double-Crane Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer